πŸ‡ΊπŸ‡Έ FDA
Patent

US 7919621

Tricyclic inhibitors of 5-lipoxygenase

granted A61PA61P11/00A61P11/02

Quick answer

US patent 7919621 (Tricyclic inhibitors of 5-lipoxygenase) held by AMIRA PHARMACEUTICALS, INC. expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AMIRA PHARMACEUTICALS, INC.
Grant date
Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P11/00, A61P11/02, A61P11/06, A61P19/08